Unlock the Science Behind Retatrutide — The Triple-Action Peptide Rewriting Weight Loss
What if one peptide could flip three metabolic switches at the same time? Retatrutide — Eli Lilly's groundbreaking triple receptor agonist — simultaneously activates GLP-1, GIP, and glucagon pathways, delivering up to 24% body weight loss in clinical trials. This is not another fad. It's precision metabolic medicine. Dive deep into the science with iThrive Healing & Beyond and understand exactly how your hormones govern weight — and how retatrutide resets them all.